Tag: Bristol Myers Squibb pharmaceuticals Alzheimer’s treatment
Alzheimer’s Identified as Key Market for Bristol Myers Squibb’s New Schizophrenia Drug
**Alzheimer's Identified as Key Market for Bristol Myers Squibb's New Schizophrenia Drug**In a groundbreaking move, Bristol Myers Squibb has set its sights on revolutionizing the treatment landscape for Alzheimer's disease with its newly approved...







